Publications by authors named "J C Roder"

Purpose: Next-generation sequencing (NGS) tools have clinical advantages over blood culture but are more expensive. This study assesses the budget impact and break-even point of NGS testing costs from a healthcare provider's perspective in Germany.

Methods: The budget impact was calculated based on aggregated data of German post-operative surgery cases.

View Article and Find Full Text PDF

Extrusion-based bioprinting is an established method in biofabrication. Suitable bioinks have fundamentally different compositions and characteristics, which should be examined, in order to find a perfect model system. Here, we investigate the effect of two alginate-based, yet unalike 3D-printed bioinks, pre-crosslinked alginate-dialdehyde gelatin (ADA-GEL) and a mixture of alginate, hyaluronic acid, and gelatin (Alg/HA/Gel), on the melanoma cell line Mel Im and vice versa in terms of stiffness, shrinkage, cellular behavior and colony formation over 15 days.

View Article and Find Full Text PDF

While the usual etiology of slipped capital femoral epiphysis (SCFE) is idiopathic, there are many other factors that increase the predisposition to slippage. Chemotherapy can be one of them. In this article, we report a rare case of acute SCFE after tumor prosthesis implantation in a patient who received chemotherapy.

View Article and Find Full Text PDF

Bioprinting has evolved into a thriving technology for the fabrication of cell-laden scaffolds. Bioinks are the most critical component for bioprinting. Recently, microgels have been introduced as a very promising bioink, enabling cell protection and the control of the cellular microenvironment.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers engineered NK-92 cells with a special receptor (NKAR) that enhances their ability to recognize and kill specific cancer cells, using a combination of IL-15 to boost their activity and bispecific antibodies that target EGFR or ErbB2.
  • * When tested, the engineered NK cells effectively killed glioblastoma cells that expressed high levels of these target antigens, especially when both bispecific antibodies were used together, demonstrating a promising strategy for improving cancer treatment by preventing immune escape.
View Article and Find Full Text PDF